Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin for Treating Left Ventricular Thrombus.
John HeraldJesse GoitiaLewei DuanAiyu ChenMing-Sum LeePublished in: American journal of cardiovascular drugs : drugs, devices, and other interventions (2022)
In this diverse population-based cohort of patients, DOAC treatment for left ventricular thrombus appears to be as safe and effective as warfarin treatment. These findings support the use of DOACs for patients with left ventricular thrombus.
Keyphrases
- direct oral anticoagulants
- left ventricular
- venous thromboembolism
- atrial fibrillation
- heart failure
- acute myocardial infarction
- end stage renal disease
- hypertrophic cardiomyopathy
- randomized controlled trial
- cardiac resynchronization therapy
- mitral valve
- systematic review
- newly diagnosed
- chronic kidney disease
- peritoneal dialysis
- patient reported outcomes
- coronary artery disease
- combination therapy
- oral anticoagulants